Patricia Castelli, | |
1500 E Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109-5000 | |
(734) 936-4566 | |
Not Available |
Full Name | Patricia Castelli |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 16 Years |
Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073772083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 4301092285 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Upmc St Margaret | Pittsburgh, PA | Hospital |
Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
Upmc East | Monroeville, PA | Hospital |
Upmc Mckeesport Hospital | Mc keesport, PA | Hospital |
Upmc Passavant | Pittsburgh, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
The rate of mortality from breast cancer has fallen by one third over the last 30 years. This is due to improvements in early detection, the refinement of treatment concepts and the development of new ones.
The MDI Biological Laboratory and the University of New England are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine.
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
Microsoft Corp. today announced that people using the Google Health service, scheduled to be discontinued Jan. 1, 2012, can easily transfer their personal health information stored in a Google Health profile to a Microsoft HealthVault account using the Direct Project messaging protocols established by the Office of the National Coordinator for Health IT.
› Verified 9 days ago
Entity Name | University Of Pittsburgh Cancer Institute Cancer Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427025840 PECOS PAC ID: 6709771587 Enrollment ID: O20040219000811 |
News Archive
The rate of mortality from breast cancer has fallen by one third over the last 30 years. This is due to improvements in early detection, the refinement of treatment concepts and the development of new ones.
The MDI Biological Laboratory and the University of New England are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine.
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
Microsoft Corp. today announced that people using the Google Health service, scheduled to be discontinued Jan. 1, 2012, can easily transfer their personal health information stored in a Google Health profile to a Microsoft HealthVault account using the Direct Project messaging protocols established by the Office of the National Coordinator for Health IT.
› Verified 9 days ago
Entity Name | University Of Pittsburgh Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
The rate of mortality from breast cancer has fallen by one third over the last 30 years. This is due to improvements in early detection, the refinement of treatment concepts and the development of new ones.
The MDI Biological Laboratory and the University of New England are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine.
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
Microsoft Corp. today announced that people using the Google Health service, scheduled to be discontinued Jan. 1, 2012, can easily transfer their personal health information stored in a Google Health profile to a Microsoft HealthVault account using the Direct Project messaging protocols established by the Office of the National Coordinator for Health IT.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Patricia Castelli, 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108-1633 Ph: () - | Patricia Castelli, 1500 E Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109-5000 Ph: (734) 936-4566 |
News Archive
The rate of mortality from breast cancer has fallen by one third over the last 30 years. This is due to improvements in early detection, the refinement of treatment concepts and the development of new ones.
The MDI Biological Laboratory and the University of New England are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine.
Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.
The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
Microsoft Corp. today announced that people using the Google Health service, scheduled to be discontinued Jan. 1, 2012, can easily transfer their personal health information stored in a Google Health profile to a Microsoft HealthVault account using the Direct Project messaging protocols established by the Office of the National Coordinator for Health IT.
› Verified 9 days ago
Chiemezie Chianotu Amadi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Patrick Charles Albus, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Michael James Todd, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Perry G Pernicano, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109 Phone: 734-936-4566 | |
Ellen G Hoeffner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp C, Ann Arbor, MI 48109 Phone: 734-936-4566 | |
Dr. Christopher Robert Nall, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Stephen Michael Ascherl, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2375 Newport Rd, Ann Arbor, MI 48103 Phone: 734-327-0649 Fax: 734-327-0649 |